This is a pivotal time for policymakers to be vigilant about drug shortages and to ensure that Canadians have reliable access to safe drugs.
Academic rigor, journalistic flair
Articles on Hydroxychloroquine
Displaying 21 - 37 of 37 articles
The only way to know if a medical treatment actually works is with a randomized-controlled trial.
A simple head-to-head trial would resolve this conflict once and for all.
Do mutations that alter the addition of sugars to the coat of the virus affect the severity of the disease?
Researchers at the University of California, San Francisco, identified nine existing drugs that show promise to treat COVID-19. The proteins they target haven’t been tried before.
In Ontario, the task of deciding which treatments to use for COVID-19 patients falls to two committees that weigh the evidence and choose which drugs to use, and how to manage critical illness.
What does high blood sugar have to do with vulnerability to COVID-19? And is there a role for the controversial drug hydroxychloroquine in lowering blood sugar in COVID-19 patients?
Coronavirus drug trials are underway – a virologist explains what the treatment options may be.
Alberta Premier Jason Kenney said he would not wait for Health Canada approval for coronavirus treatments and vaccines.
With recent calls for their use in combating COVID-19, there are concerns that chloroquine and hydroxychloroquine might become unavailable to people who need them.
Researchers, scientific journals and health agencies are doing everything they can to speed up coronavirus research. The combination of pace and panic during this pandemic is causing mistakes.
To battle the coronavirus, strong regulatory protection from the FDA is essential.
The president promoted the combination of hydroxychloroquine and an antibiotic for treating COVID-19. But a new study suggests it provides no benefits.
Cinchona bark, the flavouring in tonic water, is not a natural source of chloroquine.
Taking these drugs to treat COVID-19 without medical advice has caused poisonings and death.
A medicinal chemist addresses questions about chloroquine and hydroxychloroquine: what it is, whether it is effective against COVID-19 and whether it can treat and/or prevent this disease.
People who have rheumatoid arthritis often suffer from depression as well. For poor people this is often worse because they cut off their social networks.
Top contributors
-
Professor of Chemistry and Biochemistry and President-Elect of the International Society for Antiviral Research, University of Maryland, Baltimore County
-
Professor of Medicine, University of Pittsburgh
-
Lecturer in Virology, Queen's University Belfast
-
Professor, School of Public Health, University of Gothenburg Sweden, University of the Witwatersrand
-
Research Assistant Professor, Division of Medical Ethics, New York University
-
Rheumatologist, University of Cape Town
-
Head of School and Dean of Pharmacy, University of Sydney
-
Professor and Director of the Stoneygate Centre for Excellence in Empathic Healthcare, University of Leicester
-
Professor of Law, Boston University
-
Senior Lecturer in Chemical Pathology, University of Westminster
-
Dornsife Endowed Professor of Global Health, Drexel University
-
Distinguished Professor of Pharmacy Practice, University of Connecticut
-
Associate Professor of Religion, USC Dornsife College of Letters, Arts and Sciences
-
Associate Professor, Faculty of Law and Cumming School of Medicine; Member, AMR One Health Consortium, University of Calgary
-
Board Certified Internal Medicine Physician and Public Health Scientist, MidMichigan Health, University of Michigan
